Literature DB >> 16145064

Development of effective new treatments for multiple myeloma.

Kenneth C Anderson1, Richard Pazdur, Ann T Farrell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16145064     DOI： 10.1200/JCO.2005.02.4950

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  The 39th David A. Karnofsky Lecture: bench-to-bedside translation of targeted therapies in multiple myeloma.

Authors:  Kenneth C Anderson
Journal:  J Clin Oncol       Date:  2012-01-03       Impact factor: 44.544

2.  Combination chemotherapy increases cytotoxicity of multiple myeloma cells by modification of nuclear factor (NF)-κB activity.

Authors:  Kelley Salem; Charles O Brown; Jeanine Schibler; Apollina Goel
Journal:  Exp Hematol       Date:  2012-10-11       Impact factor: 3.084

3.  Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP.

Authors:  Li Hua Wang; Xiao Yi Yang; Xiaohu Zhang; William L Farrar
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

4.  Response to dexamethasone is glucose-sensitive in multiple myeloma cell lines.

Authors:  Ellen Friday; Johnathan Ledet; Francesco Turturro
Journal:  J Exp Clin Cancer Res       Date:  2011-09-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.